Genetics to improve fungal infection treatment
Part of Blood & lymphatic, Cancer, Infections clinical trials.
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 years old or older.
- You have decided to take the medication voriconazole.
- You are admitted to a hospital participating in the trial or can come for regular follow-up visits.
- You have not received a stem cell transplant from a donor without having a DNA sample from before the transplant.
- You are not expected to pass away within the next 7 days.
- You have not been in this trial before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a personalized way to decide the first maintenance dose of voriconazole, an antifungal medicine for people with blood cancers. It uses a genetic test to help determine the best dose for you.
This trial tests whether using a targeted antifungal medicine (aimed at PTX3) can better prevent serious fungal infections in adults with AML or a related bone marrow disease who will have very low neutrophils. It may help lower the risk of dangerous infections during intensive chemotherapy hospital stays.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
This trial tests BSG005, a new IV medicine for patients with invasive fungal infections that haven't improved with standard treatment or can't use standard treatments due to side effects or resistance. The goal is to see if it's safe and effective.
This study tests whether a sensitive blood test can find hidden fungal infections in people with blood cancers. It may help your doctor start the right treatment sooner.
Hear when a new Fungal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.